Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rx Safety: FDA Needs Deadline - Not Funding - To Improve Process, GAO Says

Executive Summary

GAO is not buying an FDA assertion that the delay in giving the Office of Surveillance and Epidemiology more responsibility for post-market drug safety decisions is a funding issue

You may also be interested in...



Sentinel Initiative Needs Better Defined Goals, Outside Review Concludes

The Pharmacovigilance Review Subcommittee of FDA's Science Board reports a lack of clarity within CDER over just what purpose the drug safety program is supposed to serve.

CDER “Equal Voice” Policy Does Not Mean Equal Weight In Decision-Making

The Center for Drug Evaluation and Research’s new internal guidelines implementing the “Equal Voice” initiative suggest each scientific discipline’s perspective will be given equal time, but not equal weight.

CDER “Equal Voice” Policy Does Not Mean Equal Weight In Decision-Making

The Center for Drug Evaluation and Research’s new internal guidelines implementing the “Equal Voice” initiative suggest each scientific discipline’s perspective will be given equal time, but not equal weight.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS051770

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel